Trials / Unknown
UnknownNCT00258141
Study With Rupatadine in Mosquito-Bite Allergic Adult Subjects
A Placebo-Controlled, Double-Blind, Cross-Over Study With Rupatadine 10 Mg in 30 Mosquito-Bite Allergic Adult Subjects
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (planned)
- Sponsor
- J. Uriach and Company · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The study will find out how effective rupatadine is in the treatment of mosquito bite symptoms in adult patients allergic to mosquito bites.
Detailed description
Mosquito-bite symptoms include wheals and pruritic bite papules. Oral antihistamines have shown to decrease whealing ang accompanying pruritus in placebo-controlled trials. Subjects will be treated for 4 days, and exposed to experimental mosquito bite at day 3.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rupatadine | |
| DRUG | Placebo |
Timeline
- First posted
- 2005-11-24
- Last updated
- 2005-11-24
Locations
2 sites across 1 country: Finland
Source: ClinicalTrials.gov record NCT00258141. Inclusion in this directory is not an endorsement.